21 November 2025
21 November 2025
The CDC said the claim “vaccines do not cause autism” is not evidence-based, contrary to medical consensus.
Valo will use its trove of patient records and biobank samples to pinpoint potential targets for Merck’s pipeline expansion.
Innovative linkers, connecting antibodies to payloads, are fine-tuning ADC selectivity while broadening their therapeutic scope.
Though CMC barriers remain, strategic planning in the early development stages can guide a CGT product to success.
The initiative forms part of Moderna’s continued investment in US-based infrastructure.
Gobivaz can treat juvenile idiopathic arthritis in children aged two and above when used with methotrexate.
The funding round was jointly led by OrbiMed, Frazier Life Sciences, ARCH Venture Partners and Revelation Partners.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
